PharmAust’s cancer fighting drugs continue to inhibit COVID-19 in its testing of the effects of the drugs on cultured cells infected by the virus. Preliminary results from lab studies undertaken for PharmAust by the Walter and Eliza Hall Institute of Medical Research in Melbourne show the virus can be suppressed by up to about 95 per cent following treatment with the company’s monepantel and monepantel sulfone products.
25/08/2020 - 16:41
PharmAust tests continue to hit high COVID-19 suppression rates
By Matt Birney
25/08/2020 - 16:41
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX